Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Continuous peritoneal ropivacaine infusion after pediatric laparoscopy
2008-002724-29Phase 3Active
- Sponsor
- IRCCS Burlo Garofolo
- Start
- Jun 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in postoperative pain comparing Ropivacaine continuous peritoneal infusion with Placebo continuous peritoneal infusion (2 arms). Primary endpoint: Postoperative pain over 24 hours. Started Jun 2008; status: active.
02
Drugs
ropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on 2008-002724-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-002724-29.